title: A comparison of TMD patients with or without prior motor vehicle accident involvement: treatment and outcomes.
abstract: The influence of previous trauma in the management of patients with temporomandibular disorders (TMD) is controversial. The objectives of this study were to compare treatment regimens and outcomes in motor vehicle accident trauma-related versus nontrauma-related TMD patients. Files of 50 trauma and 50 matched nontrauma TMD patients were reviewed. Information concerning treatment received, progress of symptoms with treatment, and findings from the final examination were recorded. As a whole group, posttraumatic TMD patients tended to receive more types of treatment (P < .0001), have more medications prescribed (including analgesics, P < .001; nonsteroidal anti-inflammatory drugs, P = .001; muscle relaxants, P = .001; and tricyclic antidepressants, P < .001), have more oral medicine clinic visits (P = .07) over a longer period of time (P = .06), and have a poorer treatment outcome (P < .001) as compared to the nontrauma group. When the patients were separated into TMD diagnostic classification subsets, only some of these differences between trauma and nontrauma patients were seen, but the subset group sizes were small and only a few of the groups could be compared. There did not seem to be a significant effect from settling insurance claims prior to the last clinic visit. Trauma may be an important prognostic factor in the management of some TMD patients.
authors.affiliation: Department of Diagnostic and Surgical Sciences, University of Saskatchewan, College of Dentistry, Saskatoon, Canada.
authors.forename: D A
authors.initials: DA
authors.lastname: Kolbinson
authors.forename: J B
authors.initials: JB
authors.lastname: Epstein
authors.forename: A
authors.initials: A
authors.lastname: Senthilselvan
authors.forename: J A
authors.initials: JA
authors.lastname: Burgess
mesh_terms: D000063:Accidents, Traffic; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000779:Anesthetics, Local / Q000008:administration & dosage; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001178:Arthroplasty; D016009:Chi-Square Distribution; D005260:Female; D006801:Humans; D008297:Male; D008405:Massage; D008446:Maxillofacial Injuries / Q000150:complications*; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D017090:Occlusal Splints; D011379:Prognosis; D018709:Statistics, Nonparametric; D013705:Temporomandibular Joint Disorders / Q000209:etiology* / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D000701:Analgesics, Opioid; D000779:Anesthetics, Local; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000929:Antidepressive Agents, Tricyclic; D009125:Muscle Relaxants, Central